Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma: A single-center experience

Oncology (Switzerland)

Volumn 89, Issue , 2015, Pages 27-32

  Minami, Yasunori ^a   Minami, Tomohiro ^a   Chishina, Hirokazu ^a   Arizumi, Tadaaki ^a   Takita, Masahiro ^a   Kitai, Satoshi ^a   Yada, Norihisa ^a   Hagiwara, Satoru ^a   Tsurusaki, Masakatsu ^b   Yagyu, Yukinobu ^b   Ueshima, Kazuomi ^a   Nishida, Naoshi ^a   Murakami, Takamichi ^b   Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Balloon occluded transcatheter arterial chemoembolization; Hepatocellular carcinoma

Indexed keywords

MIRIPLATIN; ANTINEOPLASTIC AGENT; ETHIODIZED OIL;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; BALLOON OCCLUSION; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; DRUG THERAPY; FOLLOW UP; IMAGE PROCESSING; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BALLOON OCCLUSION; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; ETHIODIZED OIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84965092696     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000440628     Document Type: Article

References (34)

1. Llovet JM, Real MI, Montana X, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002; 359: 1734-1739.
2. Marelli L, Stigliano R, Triantos C, et al: Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30: 6-25.
3. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
4. Takayasu K, Arii S, Ikai I, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8,510 patients. Gastroenterology 2006; 131: 461-469.
5. Sergio A, Cristofori C, Cardin R, et al: Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): The role of angiogenesis and invasiveness. Am J Gastroenterol 2008; 103: 914-921.
6. Lencioni R: Chemoembolization for hepatocellular carcinoma. Semin Oncol 2012; 39: 503-509.
7. Lencioni R: Chemoembolization in patients with hepatocellular carcinoma. Liver Cancer 2012; 1: 41-50.
8. Minami Y, Yagyu Y, Murakami T, Kudo M: Tracking navigation imaging of transcatheter arterial chemoembolization for hepatocellular carcinoma using three-dimensional conebeam CT angiography. Liver Cancer 2014; 3: 53-61.
9. Minami Y, Kudo M: Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging. Oncology 2013; 84(suppl 1):58-63.
10. Minami Y, Kudo M, Kawasaki T, et al: Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003; 180: 703-708.
11. Lee JK, Chung YH, Song BC, et al: Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 2002; 17: 52-58.
12. Irie T, Kuramochi M, Takahashi N: Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol 2013; 36: 706-713.
13. Arai H, Abe T, Takayama H, et al: Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatol Res 2015; 45: 663-666.
14. Ogawa M, Takayasu K, Hirayama M, et al: Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: short-Term results. Hepatol Res 2015, Epub ahead of print.
15. Golfieri R, Cappelli A, Cucchetti A, et al: Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (
16. Livraghi T, Brambilla G, Carnaghi C, et al: Is it time to reconsider the BCLC/AASLD therapeutic flow-chart? J Surg Oncol 2010; 102: 868-876.
17. Kudo M, Kubo S, Takayasu K, et al: Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). Hepatol Res 2010; 40: 686-692.
18. Kudo M, Izumi N, Kokudo N, et al: Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-364.
19. Llovet JM, Ducreux M, et al: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.
20. Park JW, Amarapurkar D, Chao Y, et al: Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver Int 2013; 33: 327-337.
21. Ogasawara S, Chiba T, Ooka Y, et al: Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization. Oncology 2014; 87: 330-341.
22. Raoul JL, Gilabert M, Piana G: How to define transarterial chemoembolization failure or refractoriness: A European perspective. Liver Cancer 2014; 3: 119-124.
23. Kim HY, Park JW: Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future. Liver Cancer 2014; 3: 9-17.
24. Peck-Radosavljevic M: Drug therapy for advanced-stage liver cancer. Liver Cancer 2014; 3: 125-131.
25. Bruix J, Llovet JM, Castells A, et al: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-1583.
26. Kudo M, Matsui O, Izumi N, et al: JSH Consensus-Based Clinical Practice Guideline for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer 2014; 3: 458-468.
27. Kudo M, Matsui O, Izumi N, et al: Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update. Oncology 2014; 87(suppl 1):22-31.
28. Yamashita T: Current status of hepatocellular carcinoma treatment in Japan: hepatic arterial infusion chemotherapy. Clin Drug Invest 2012; 32(suppl 2):15-23.
29. Kudo M: Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver Cancer 2015; 4: 39-50.
30. Ikeda M, Okusaka T, Furuse J, et al: A multiinstitutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemother Pharmacol 2013; 72: 463-470.
31. Ueshima K, Kudo M, Takita M, et al: Hepatic arterial infusion chemotherapy using lowdose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma. Oncology 2010; 78(suppl 1):148-153.
32. Ueshima K, Kudo M, Nagai T, et al: Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma. Oncology 2008; 75(suppl 1):106-113.
33. Obi S, Yoshida H, Toune R, et al: Combination therapy of intraarterial 5-fluorouracil and systemic interferon-Alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006; 106: 1990-1997.
34. Nagano H, Miyamoto A, Wada H, et al: Interferon-Alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer 2007; 110: 2493-2501.